focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.50
Bid: 61.00
Ask: 62.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.639%)
Open: 61.50
High: 61.50
Low: 61.50
Prev. Close: 61.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Torex Retail-Amend

14 Jun 2007 16:23

Deutsche Bank AG London14 June 2007 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) AMENDMENT - Previous disclosure related to conversion of CB into Ordinary Shares. 1. KEY INFORMATION Name of person dealing (Note 1) Deutsche Bank AG London Company dealt in Torex Retail Plc 5.5% Convertible Bond 2011 Class of relevant security to which the Convertible Bonddealings being disclosed relate (Note 2) Date of dealing 08/06/2007 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class ofrelevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 4,300,000 6.615 (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 4,300,000 6.615 (b) Interests and short positions in relevant securities of the company,other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Sale 2,000,000 £74.00 (b) Derivatives transactions (other than options) Product name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5) e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 7) price European etc. date paid/received per unit (Note 5) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 14/06/2007 Contact name Kelly-Jade Ledwich Telephone number 020 7545 7804 If a connected EFM, name of offeree/offeror with which connected N/A If a connected EFM, state nature of connection (Note 10) N/A Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Feb 20213:52 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSMove to Electronic Reporting
8th Feb 20217:00 amRNSTrading Update
5th Feb 20214:40 pmRNSSecond Price Monitoring Extn
5th Feb 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSAppointment of Chief Financial Officer
6th Jan 20213:58 pmRNSPDMR Dealings
5th Jan 20217:00 amRNSConfirmation of Board appointments
4th Jan 202111:26 amRNSHoldings in Company
24th Dec 202012:56 pmRNSIssue of Equity & Total Voting Rights Replacement
24th Dec 202011:15 amRNSHoldings in Company
23rd Dec 20209:51 amRNSIssue of Equity and Total Voting Rights
4th Dec 20207:00 amRNSBoard Changes
3rd Dec 20204:54 pmRNSHoldings in Company
2nd Dec 20207:00 amRNSFirst delivery of OrthoPure® XT
27th Nov 20209:09 amRNSHoldings in Company
26th Nov 20204:02 pmRNSHoldings in Company
17th Nov 20207:00 amRNSAppointment of CEO
6th Nov 20207:00 amRNSHoldings in Company
29th Oct 20207:00 amRNSHoldings in Company
29th Oct 20207:00 amRNSChange of Registered Office
26th Oct 20204:50 pmRNSHoldings in Company
7th Oct 20201:50 pmEQSHardman & Co Research: Tissue Regenix (TRX): Funded through to profitability
28th Sep 202012:24 pmRNSHoldings in Company
16th Sep 20207:42 amRNSHoldings in Company
15th Sep 20204:40 pmRNSSecond Price Monitoring Extn
15th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20205:33 pmRNSHoldings in Company
2nd Sep 20207:00 amRNSUnaudited Interim Results
27th Aug 20207:00 amRNSNotice of Interim Results & Investor Presentation
24th Aug 20207:00 amRNSUK distribution partner for OrthoPure® XT
18th Aug 202011:27 amRNSHoldings in Company
17th Aug 20207:00 amRNSRelocation of UK office and manufacturing facility
27th Jul 20209:59 amRNSHoldings in Company
24th Jul 20207:00 amRNSCommencement of facility expansion plan
23rd Jul 20206:22 pmRNSHoldings in Company
17th Jul 20209:56 amRNSHoldings in Company
10th Jul 20203:18 pmRNSHoldings in Company
6th Jul 20209:31 amRNSHoldings in Company
3rd Jul 202010:01 amRNSHoldings in Company
30th Jun 20204:44 pmRNSTotal Voting Rights
30th Jun 202010:42 amRNSResult of AGM
23rd Jun 20203:07 pmRNSOption Exercise and Total Voting Rights
17th Jun 202012:57 pmRNSHoldings in Company
15th Jun 20202:06 pmRNSSecond Price Monitoring Extn
15th Jun 20202:00 pmRNSPrice Monitoring Extension
15th Jun 202011:31 amRNSHoldings in Company
11th Jun 20204:54 pmRNSHoldings in Company
11th Jun 20204:26 pmRNSHoldings in Company
11th Jun 20201:21 pmRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.